Two European firms ally in PET

Alliance Medical of Oxfordshire and M2i of Dublin have formed a joint venture to produce and distribute PET radiopharmaceuticals in the U.K. The new company, called Molecular Imaging Services, will focus on the production of F-18 FDG (fluorodeoxyglucose) through a series of dedicated radiopharmaceutical production units. These units will serve both hospital-based PET facilities and mobile PET scanners. Alliance Medical operates two PET scanners in the U.K.: a stationary unit at a facility located in London and a mobile PET scanner serving three hospitals. The mobile PET will soon begin serving a fourth hospital.